Trial · NCT05030129

Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Ergoloid Mesylates (EM) and 5-hydroxytryptophan (5-HTP)	0	15
Total, all-cause mortality	Placebo	0	15
Total, all-cause mortality	Ergoloid Mesylates (EM) and Placebo	0	15
Total, all-cause mortality	5-hydroxytryptophan (5-HTP) and Placebo	0	15
Total, other adverse events	Ergoloid Mesylates (EM) and 5-hydroxytryptophan (5-HTP)	1	15
Total, other adverse events	Placebo	3	15
Total, other adverse events	Ergoloid Mesylates (EM) and Placebo	2	15
Total, other adverse events	5-hydroxytryptophan (5-HTP) and Placebo	1	15
Total, serious adverse events	Ergoloid Mesylates (EM) and 5-hydroxytryptophan (5-HTP)	0	15
Total, serious adverse events	Placebo	0	15
Total, serious adverse events	Ergoloid Mesylates (EM) and Placebo	0	15
Total, serious adverse events	5-hydroxytryptophan (5-HTP) and Placebo	0	15

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05030129/event-totals